ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

NIH, NCI Being Discussions With HCFA On Reimbursement

April 26, 1996

In Brief: NCAB Appointments: Boutwell Stay On; Brown, Elion, Strong, Korn Named; One Vacancy Remains

May 18, 1984

New HIP Analysis Supports Mammography Screening Ages 40-49

September 23, 1988

Eight Scientists Receive $800,000 From Milken

January 5, 1990

Kennedy Agrees To Drop Dollar Limit In New Cancer Bill

January 11, 1980

New Funding Mechanisms – Cooperative Agreement, Consortium Grant – Proposed For Clinical Groups

April 6, 1979